Jay P. Parrish
32Patents
16h-index
53Co-inventors
80Inventor score
Filing activity: Apr 23, 2004 → May 22, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8008264B2 | 1′-substituted carba-nucleoside analogs for antiviral treatment | Emerging Cross-Sectional Technologies | 108 | Active |
| US8012941B2 | Carba-nucleoside analogs for antiviral treatment | Emerging Cross-Sectional Technologies | 99 | Active |
| US8318682B2 | 1′substituted carba-nucleoside analogs for antiviral treatment | Emerging Cross-Sectional Technologies | 95 | Active |
| US8853171B2 | 1′-substituted carba-nucleoside analogs for antiviral treatment | Emerging Cross-Sectional Technologies | 62 | Active |
| US8088368B2 | Antiviral compounds | Chemistry; Metallurgy | 57 | Active |
| US8324179B2 | Nucleoside analogs for antiviral treatment | Chemistry; Metallurgy | 54 | Active |
| US9724360B2 | Methods for treating Filoviridae virus infections | Emerging Cross-Sectional Technologies | 47 | Active |
| US9949994B2 | Methods for treating Filoviridae virus infections | Emerging Cross-Sectional Technologies | 42 | Active |
| US10065958B2 | Methods and compounds for treating Paramyxoviridae virus infections | Emerging Cross-Sectional Technologies | 37 | Active |
| US10251898B2 | Methods for treating Filoviridae virus infections | Emerging Cross-Sectional Technologies | 35 | Active |
| US8273341B2 | Antiviral compounds | Chemistry; Metallurgy | 33 | Active |
| US10696679B2 | Methods and compounds for treating paramyxoviridae virus infections | Emerging Cross-Sectional Technologies | 27 | Active |
| USRE46762E1 | 1′-substituted carba-nucleoside analogs for antiviral treatment | General | 27 | Active |
| US10695357B2 | Methods for treating filoviridae virus infections | Emerging Cross-Sectional Technologies | 27 | Active |
| US11266666B2 | Methods for treating Filoviridae virus infections | Emerging Cross-Sectional Technologies | 23 | Active |
| US11492353B2 | Methods and compounds for treating Paramyxoviridae virus infections | Emerging Cross-Sectional Technologies | 17 | Active |
| US8575118B2 | Antiviral compounds | Chemistry; Metallurgy | 16 | Active |
| US8669234B2 | Antiviral compounds | Chemistry; Metallurgy | 15 | Active |
| US8486938B2 | Pyrazolo[1,5-a]pyrimidines for antiviral treatment | Chemistry; Metallurgy | 14 | Active |
| US8841278B2 | Antiviral compounds | Chemistry; Metallurgy | 11 | Active |
| US8809330B2 | Pyrazolo[1,5-A]pyrimidines for antiviral treatment | Chemistry; Metallurgy | 9 | Active |
| US8822430B2 | Antiviral compounds | Chemistry; Metallurgy | 8 | Active |
| US8980878B2 | Compounds and methods for antiviral treatment | Chemistry; Metallurgy | 8 | Active |
| US9511056B2 | Antiviral compounds | Chemistry; Metallurgy | 6 | Active |
| US8946238B2 | Pyrazolo[1,5-A]pyrimidines as antiviral agents | Chemistry; Metallurgy | 6 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.